NFE2 levels are increased in the majority of MPN patients, and transgenic mice expressing elevated NFE2 levels develop an MPN-like phenotype with spontaneous transformation to acute leukemia (AML), at a rate similar to that observed in MPN patients [1,2,3]. Here, NFE2 is linked to myeloproliferative disorder.